Molecular characterization of the multidrug resistant escherichia coli ST131 clone

Pathogens

Volumn 4, Issue 3, 2015, Pages 422-430

  Schembri, Mark A ^a   Ben Zakour, Nouri L ^a   Phan, Minh Duy ^a   Forde, Brian M ^a   Stanton Cook, Mitchell ^a   Beatson, Scott A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antibiotic resistance; FimH; Genomics; Plasmid; ST131; TraDIS; Urinary tract; Uropathogenic Escherichia coli; Virulence

Indexed keywords

PLASMID VECTOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ALLELE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOODSTREAM INFECTION; DRUG RESISTANCE; ESCHERICHIA COLI; GENE SEQUENCE; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; PHYLOGENY; REVIEW; TRANSPOSON; URINARY TRACT INFECTION;

EID: 85017113272     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens4030422     Document Type: Review

References (35)

1. Flores-Mireles, A.L.; Walker, J.N.; Caparon, M.; Hultgren, S.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015, 13, 269-284.
2. Riley, L.W. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin. Microbiol. Infect. 2014, 20, 380-390.
3. Mathers, A.J.; Peirano, G.; Pitout, J.D. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant enterobacteriaceae. Clin. Microbiol. Rev. 2015, 28, 565-591.
4. Coque, T.M.; Novais, A.; Carattoli, A.; Poirel, L.; Pitout, J.; Peixe, L.; Baquero, F.; Canton, R.; Nordmann, P. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase ctx-m-15. Emerg. Infect. Dis. 2008, 14, 195-200.
5. Lau, S.H.; Reddy, S.; Cheesbrough, J.; Bolton, F.J.; Willshaw, G.; Cheasty, T.; Fox, A.J.; Upton, M. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J. Clin. Microbiol. 2008, 46, 1076-1080.
6. Nicolas-Chanoine, M.H.; Blanco, J.; Leflon-Guibout, V.; Demarty, R.; Alonso, M.P.; Canica, M.M.; Park, Y.J.; Lavigne, J.P.; Pitout, J.; Johnson, J.R. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008, 61, 273-281.
7. D'Andrea, M.M.; Arena, F.; Pallecchi, L.; Rossolini, G.M. CTX-M-type β-lactamases: A successful story of antibiotic resistance. Int. J. Med. Microbiol. 2013, 303, 305-317.
8. Canton, R.; Coque, T.M. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 2006, 9, 466-475.
9. Nicolas-Chanoine, M.H.; Bertrand, X.; Madec, J.Y. Escherichia coli ST131, an intriguing clonal group. Clin. Microbiol. Rev. 2014, 27, 543-574.
10. Rogers, B.A.; Sidjabat, H.E.; Paterson, D.L. Escherichia coli O25b-ST131: A pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 2011, 66, 1-14.
11. Banerjee, R.; Johnson, J.R. A new clone sweeps clean: The enigmatic emergence of Escherichia coli sequence type 131. Antimicrob. Agents Chemother. 2014, 58, 4997-5004.
12. Qureshi, Z.A.; Doi, Y. Escherichia coli sequence type 131: Epidemiology and challenges in treatment. Expert Rev. Anti Infect. Ther. 2014, 12, 597-609.
13. Johnson, J.R.; Tchesnokova, V.; Johnston, B.; Clabots, C.; Roberts, P.L.; Billig, M.; Riddell, K.; Rogers, P.; Qin, X.; Butler-Wu, S.; et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 2013, 207, 919-928.
14. Toh, H.; Oshima, K.; Toyoda, A.; Ogura, Y.; Ooka, T.; Sasamoto, H.; Park, S.H.; Iyoda, S.; Kurokawa, K.; Morita, H.; et al. Complete genome sequence of the wild-type commensal Escherichia coli strain SE15, belonging to phylogenetic group B2. J. Bacteriol. 2010, 192, 1165-1166.
15. Forde, B.M.; Ben Zakour, N.L.; Stanton-Cook, M.; Phan, M.D.; Totsika, M.; Peters, K.M.; Chan, K.G.; Schembri, M.A.; Upton, M.; Beatson, S.A. The complete genome sequence of Escherichia coli EC958: A high quality reference sequence for the globally disseminated multidrug resistant E. coli O25b:H4-ST131 clone. PLoS ONE 2014, 9, e104400.
16. Andersen, P.S.; Stegger, M.; Aziz, M.; Contente-Cuomo, T.; Gibbons, H.S.; Keim, P.; Sokurenko, E.V.; Johnson, J.R.; Price, L.B. Complete genome sequence of the epidemic and highly virulent CTX-M-15-producing H30-RX subclone of escherichia coli st131. Genome Announc. 2013, 1, doi:10.1128/genomeA.00988-13.
17. Avasthi, T.S.; Kumar, N.; Baddam, R.; Hussain, A.; Nandanwar, N.; Jadhav, S.; Ahmed, N. Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J. Bacteriol. 2011, 193, 4272-4273.
18. Price, L.B.; Johnson, J.R.; Aziz, M.; Clabots, C.; Johnston, B.; Tchesnokova, V.; Nordstrom, L.; Billig, M.; Chattopadhyay, S.; Stegger, M.; et al. The epidemic of extended-spectrum-β-lactamaseproducing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-RX. MBio 2013, 4, e00377-00313.
19. Petty, N.K.; Ben Zakour, N.L.; Stanton-Cook, M.; Skippington, E.; Totsika, M.; Forde, B.M.; Phan, M.D.; Gomes Moriel, D.; Peters, K.M.; Davies, M.; et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc. Natl. Acad. Sci. USA 2014, 111, 5694-5699.
20. Paul, S.; Linardopoulou, E.V.; Billig, M.; Tchesnokova, V.; Price, L.B.; Johnson, J.R.; Chattopadhyay, S.; Sokurenko, E.V. Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli. J. Bacteriol. 2013, 195, 231-242.
21. Totsika, M.; Beatson, S.A.; Sarkar, S.; Phan, M.D.; Petty, N.K.; Bachmann, N.; Szubert, M.; Sidjabat, H.E.; Paterson, D.L.; Upton, M.; et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: Genome analysis and virulence mechanisms. PLoS ONE 2011, 6, e26578.
22. Totsika, M.; Kostakioti, M.; Hannan, T.J.; Upton, M.; Beatson, S.A.; Janetka, J.W.; Hultgren, S.J.; Schembri, M.A. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. J. Infect. Dis. 2013, 208, 921-928.
23. Floyd, R.V.; Upton, M.; Hultgren, S.J.; Wray, S.; Burdyga, T.V.; Winstanley, C. Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J. Infect. Dis. 2012, 206, 1589-1596.
24. Phan, M.D.; Peters, K.M.; Sarkar, S.; Lukowski, S.W.; Allsopp, L.P.; Gomes Moriel, D.; Achard, M.E.; Totsika, M.; Marshall, V.M.; Upton, M.; et al. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet. 2013, 9, e1003834.
25. Langridge, G.C.; Phan, M.D.; Turner, D.J.; Perkins, T.T.; Parts, L.; Haase, J.; Charles, I.; Maskell, D.J.; Peters, S.E.; Dougan, G.; et al. Simultaneous assay of every Salmonella typhi gene using one million transposon mutants. Genome Res. 2009, 19, 2308-2316.
26. Bateman, S.L.; Seed, P.C. Epigenetic regulation of the nitrosative stress response and intracellular macrophage survival by extraintestinal pathogenic Escherichia coli. Mol. Microbiol. 2012, 83, 908-925.
27. Sullivan, M.J.; Petty, N.K.; Beatson, S.A. Easyfig: A genome comparison visualizer. Bioinformatics 2011, 27, 1009-1010.
28. Lanza, V.F.; de Toro, M.; Garcillan-Barcia, M.P.; Mora, A.; Blanco, J.; Coque, T.M.; de la Cruz, F. Plasmid flux in Escherichia coli ST131 sublineages, analyzed by plasmid constellation network (placnet), a new method for plasmid reconstruction from whole genome sequences. PLoS Genet. 2014, 10, e1004766.
29. Phan, M.D.; Forde, B.M.; Peters, K.M.; Sarkar, S.; Hancock, S.; Stanton-Cook, M.; Ben Zakour, N.L.; Upton, M.; Beatson, S.A.; Schembri, M.A. Molecular characterization of a multidrug resistance IncF plasmid from the globally disseminated Escherichia coli ST131 clone. PLoS ONE 2015, 10, e0122369.
30. Woodford, N.; Carattoli, A.; Karisik, E.; Underwood, A.; Ellington, M.J.; Livermore, D.M. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the united kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 2009, 53, 4472-4482.
31. CMY-23gene in the Escherichia coli ST131 reference strain EC958. J. Antimicrob. Chemother. 2015, 70, 1969-1972.
32. Johnson, T.J.; Hargreaves, M.; Shaw, K.; Snippes, P.; Lynfield, R.; Aziz, M.; Price, L.B. Complete genome sequence of a carbapenem-resistant extraintestinal pathogenic Escherichia coli strain belonging to the sequence type 131 H30R subclade. Genome Announc. 2015, 3, doi:10.1128/genomeA.00272-15.
33. Accogli, M.; Giani, T.; Monaco, M.; Giufre, M.; Garcia-Fernandez, A.; Conte, V.; D'Ancona, F.; Pantosti, A.; Rossolini, G.M.; Cerquetti, M. Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy. J. Antimicrob. Chemother. 2014, 69, 2293-2296.
34. Cai, J.C.; Zhang, R.; Hu, Y.Y.; Zhou, H.W.; Chen, G.X. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob. Agents Chemother. 2014, 58, 1146-1152.
35. Naas, T.; Cuzon, G.; Gaillot, O.; Courcol, R.; Nordmann, P. When carbapenem-hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob. Agents Chemother. 2011, 55, 4933-4934.